Yoshiyama Mitsuharu, Kobayashi Hideki, Takeda Masayuki, Araki Isao
Department of Urology, Graduate School of Medicine, University of Yamanashi, Chuo, Japan.
Shintotsuka Hospital, Yokohama, Japan.
Front Physiol. 2020 Oct 26;11:592867. doi: 10.3389/fphys.2020.592867. eCollection 2020.
We conducted this study to examine whether acid-sensing ion channels (ASICs) are involved in the modulation of urinary bladder activity with or without intravesical irritation induced by acetic acid. All evaluations were conducted during continuous infusion cystometry in decerebrated unanesthetized female mice. During cystometry with a pH 6.3 saline infusion, an i.p. injection of 30 μmol/kg A-317567 (a potent, non-amiloride ASIC blocker) increased the intercontraction interval (ICI) by 30% ( < 0.001), whereas vehicle injection had no effect. An intravesical acetic acid (pH 3.0) infusion induced bladder hyperactivity, with reductions in ICI and maximal voiding pressure (MVP) by 79% ( < 0.0001) and 29% ( < 0.001), respectively. A-317567 (30 μmol/kg i.p.) alleviated hyperreflexia by increasing the acid-shortened ICI by 76% ( < 0.001). This dose produced no effect on MVP under either intravesical pH condition. Further analysis in comparison with vehicle showed that the increase in ICI (or bladder capacity) by the drug was not dependent on bladder compliance. Meanwhile, intravesical perfusion of A-317567 (100 μM) had no effect on bladder activity during pH 6.0 saline infusion cystometry, and drug perfusion at neither 100 μM nor 1 mM produced any effects on bladder hyperreflexia during pH 3.0 acetic acid infusion cystometry. A-317567 has been suggested to display extremely poor penetrability into the central nervous system and thus to be a peripherally active blocker. Taken together, our results suggest that blockade of ASIC signal transduction increases bladder capacity under normal intravesical pH conditions and alleviates bladder hyperreflexia induced by intravesical acidification and that the site responsible for this action is likely to be the dorsal root ganglia.
我们开展这项研究,以检验酸敏感离子通道(ASICs)是否参与了在有或没有由乙酸引起的膀胱内刺激情况下膀胱活动的调节。所有评估均在去大脑未麻醉雌性小鼠的连续灌注膀胱测压过程中进行。在用pH 6.3生理盐水灌注进行膀胱测压期间,腹腔注射30 μmol/kg A-317567(一种强效的、非阿米洛利类ASIC阻滞剂)使收缩间期(ICI)增加了30%(P<0.001),而注射溶剂则没有效果。膀胱内注入乙酸(pH 3.0)会诱发膀胱活动亢进,ICI和最大排尿压力(MVP)分别降低了79%(P<0.0001)和29%(P<0.001)。A-317567(30 μmol/kg腹腔注射)通过使因酸缩短的ICI增加76%(P<0.001)来减轻反射亢进。该剂量在任何一种膀胱内pH条件下对MVP均无影响。与溶剂相比的进一步分析表明,药物引起的ICI增加(或膀胱容量增加)并不依赖于膀胱顺应性。同时,在pH 6.0生理盐水灌注膀胱测压期间,膀胱内灌注A-317567(100 μM)对膀胱活动没有影响,在pH 3.0乙酸灌注膀胱测压期间,100 μM和1 mM的药物灌注对膀胱反射亢进均未产生任何影响。A-317567被认为对中枢神经系统的穿透性极差,因此是一种外周活性阻滞剂。综上所述,我们的结果表明,在正常膀胱内pH条件下,阻断ASIC信号转导可增加膀胱容量,并减轻由膀胱内酸化引起的膀胱反射亢进,且负责此作用的部位可能是背根神经节。